For patients with RM-NPC whose primary tumor has been cleared, biopsy for PD-L1 staining is inappropriate when undergoing PD-1 combined with radiotherapy or chemotherapy as the second-line treatment. Here, CD274 is linked to nasopharyngeal carcinoma.